Proposed Changes to Community Association Management Rules

“THE TELEHEALTH MODERNIZATION ACT (H.R. 1332/ S.368) Organized a Virtual Capitol Hill Day for ACCC members (70+) on May 12th, 2021. Created one-pagers and talking points on importance of this legislation. ACCC views telehealth expansion as critical for cancer patient access to healthcare providers. THE SAFE STEP ACT (H.R.2163/S.464) Organized a Virtual Capitol Hill Day for ACCC members (70+) on May 12th, 2021. Created one-pagers and talking points on importance of this legislation. ACCC views step therapy in the use of cancer care delivery to be a hinderance to best practice and timely treatment/access of care for patients. THE ACCESS TO GENETIC COUNSELOR SERVICES ACT (H.R. 2144/S.1450) Organized a Virtual Capitol Hill Day for ACCC members (70+) on May 12th, 2021. Created one-pagers and talking points on importance of this legislation. ACCC views genetic counselors as integral members of the cancer care delivery team in oncology programs/practices in the US. THE RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT (H.R. 869/S.289) Organized a Virtual Capitol Hill Day for ACCC members (70+) on May 12th, 2021. Created one-pagers and talking points on importance of this legislation. ACCC understands the importance of research funding for the NIH and oncology investigators to promote clinical trials that impact improving cancer outcomes. THE MEDICARE MULTI-CANCER EARLY DETECTION SCREENING COVERAGE ACT OF 2021 (H.R. 1946) Organized a Virtual Capitol Hill Day for ACCC members (70+) on May 12th, 2021. Created one-pagers and talking points on importance of this legislation. ACCC advocates for the use and coverage of cancer screening modalities that will diagnose cancer at earlier stages therefore improving patient outcomes. MOST FAVORED NATION (Proposed by Trump Administration at end of 2020) ACCC entered into a lawsuit against HHS in December 2020 opposing the Most Favored Nation proposal tying drug reimbursements to international reference pricing. By lowering reimbursement to cancer programs and practices, patient access to care would be limited as supportive cancer care services limited due to lack of reimbursement to cover positions. ACCC was concerned over programs/practices closing if proposal were to move forward. ACCC met with one Senators office on this topic expressing concern in January 2021. RADIATION ONCOLOGY MODEL (Proposed by CMMI) ACCC met with 1 Senate office and 1 House office over concerns re: this alternative payment model. ACCC has concerns over mandatory nature of Radiation Oncology model testing reimbursement rates and potentially limiting access to care for patients who are recommended radiation for their cancer diagnosis, particularly in rural areas of the U.S. ”

“Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI) ”

“ACCC advocated to the US House of Representatives and US Senate on the following issues: (1) passage of a federal oral parity bill in US Congress in support of H.R. 1730 (Cancer Drug Parity Act of 2019) and S. 741 (Cancer Drug Parity Act of 2019) to see the same out of pocket cost sharing for oral chemotherapy as IV chemotherapy and (2) passage of H.R. 913 CLINICAL TREATMENT Act in support of Medicaid funding for routine care costs for cancer patients in clinical trials.”

“Excluding Part B payments from CMS' Merit Based Incentive Payment System (MIPS) adjustment under the Quality Payment Program (QPP) Reimbursement for care planning for cancer patients in the Medicare Program (The Cancer Care Planning & Communications (CCPC) Act (H.R. 5160)) ”

“Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI) ”

“Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI) ”

“Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI) ”